| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Inglis Tiffany Eul Davis | Chief Medical Officer | C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY | /s/ Benjamin G. Jackson, Attorney-in-fact | 15 Oct 2025 | 0002091798 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SERA | Class A Common Stock | Award | $0 | +75,000 | $0.000000 | 75,000 | 15 Oct 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SERA | Stock Option (right to buy) | Award | $0 | +107,000 | $0.000000 | 107,000 | 15 Oct 2025 | Class A Common Stock | 107,000 | $3.13 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date, which is October 10, 2025, and 1/12 of the remaining amount vests in quarterly installments for three years thereafter, subject to the Reporting Person continuing to provide services to the issuer. |
| F2 | These stock options vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date, which is October 10, 2025, and 1/36 of the remaining amount vests in monthly installments for three years thereafter, subject to the Reporting Person continuing to provide services to the issuer. |